Healthcare Venture Partners, Llc
Venture capitalActively deployingCharleston · Series B–Late Stage · 3 people tracked
Investment thesis
Healthcare Venture Partners invests in mid-to-late stage healthcare and life sciences companies leveraging advanced technologies. The firm pursues a diversified approach across medtech, therapeutics, healthcare services, healthcare IT, and diagnostics, believing that understanding interactions among healthcare subsectors provides critical insights for investment evaluation, monitoring, and strategy.
Source: firm website, verified Jul 21, 2026.
Team · 3 people
from the firm's website
Frequently asked questions
- What stage does Healthcare Venture Partners, Llc invest at?
- Healthcare Venture Partners, Llc invests at the Series B, Series C, Growth, Late Stage stages.
- What sectors does Healthcare Venture Partners, Llc focus on?
- Healthcare Venture Partners, Llc focuses on AI & Machine Learning, Digital Health, Healthtech, Medical Devices.
- Where is Healthcare Venture Partners, Llc located?
- Healthcare Venture Partners, Llc is headquartered in Charleston, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.
A venture capital firm that supports founders developing transformative solutions across interconnected systems, with a particular focus on leveraging artificial intelligence and related technologies to advance health and human flourishing.